|
1
|
American Thoracic Society and European
Respiratory Society. Idiopathic pulmonary fibrosis: Diagnosis and
treatment. International consensus statement. Am J Respir Crit Care
Med. 161:646–664. 2000. View Article : Google Scholar
|
|
2
|
American Thoracic Society and European
Respiratory Society. International multidisciplinary consensus
classification of the idiopathic interstitial pneumonias. Am J
Respir Crit Care Med. 165:277–304. 2002.
|
|
3
|
Raghu G, Collard HR, Egan JJ, et al:
ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis: An
official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis:
evidence-based guidelines for diagnosis and management. Am J Respir
Crit Care Med. 183:788–824. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ley B, Collard HR and King TE Jr: Clinical
course and prediction of survival in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 183:431–440. 2011. View Article : Google Scholar
|
|
5
|
Martinez FJ, Safrin S, Weycker D, et al;
IPF Study Group. The clinical course of patients with idiopathic
pulmonary fibrosis. Ann Intern Med. 142:963–967. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Olson AL, Swigris JJ, Lezotte DC, Norris
JM, Wilson CG and Brown KK: Mortality from pulmonary fibrosis
increased in the United States from 1992 to 2003. Am J Respir Crit
Care Med. 176:277–284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
King TE Jr, Albera C, Bradford WZ, et al;
INSPIRE Study Group. Effect of interferon gamma-1b on survival in
patients with idiopathic pulmonary fibrosis (INSPIRE): a
multicentre, randomised, placebo-controlled trial. Lancet.
374:222–228. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hubbard RB, Smith C, Le Jeune I, Gribbin J
and Fogarty AW: The association between idiopathic pulmonary
fibrosis and vascular disease: a population-based study. Am J
Respir Crit Care Med. 178:1257–1261. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Spátola J, Poderoso JJ, Wiemeyer JC, et
al: Influence of ambroxol on lung tissue penetration of amoxillin.
Arzneimittelforschung. 37:965–966. 1987.
|
|
10
|
Gené R, Poderoso JJ, Corazza C, Lasala MB,
Wiemeyer JC, Fernández M and Guerreiro RB: Influence of ambroxol on
amoxicillin levels in bronchoalveolar lavage fluid.
Arzneimittelforschung. 37:967–968. 1987.PubMed/NCBI
|
|
11
|
Wiemeyer JC: Influence of ambroxol on the
bronchopulmonary level of antibiotics. Arzneimittelforschung.
31:974–976. 1981.PubMed/NCBI
|
|
12
|
Szapiel SV, Elson NA, Fulmer JD,
Hunninghake GW and Crystal RG: Bleomycin-induced interstitial
pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis.
120:893–899. 1979.PubMed/NCBI
|
|
13
|
Wang F: Respiratory Tract Infection.
Infectious diseases and antimicrobial therapy. 2nd edition.
Shanghai Medical University Publishing House; Shanghai, China: pp.
216–223. 2000
|
|
14
|
Morgan EJ and Petty TL: Summary of the
National Mucolytic Study. Chest. 97(2 Suppl): 24S–27S. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhi QM, Yang LT and Sun HC: Protective
effect of ambroxol against paraquat-induced pulmonary fibrosis in
rats. Intern Med. 50:1879–1887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pozzi E, Salmona M, Masturzo P, Genghini
M, Scelsi M, Spialtini L and Luisetti M: Role of alveolar
phospholipids in bleomycin-induced pulmonary fibrosis in the rat.
Respiration. 51:23–32. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Winsel K: The antioxidative and
inflammation inhibiting properties of ambroxol. Pneumologie.
46:461–475. 1992.(In German). PubMed/NCBI
|
|
18
|
Beeh KM, Beier J, Esperester A and Paul
LD: Antiinflammatory properties of ambroxol. Eur J Med Res.
13:557–562. 2008.PubMed/NCBI
|
|
19
|
Nowak D, Antczak A, Król M, et al:
Antioxidant properties of Ambroxol. Free Radic Biol Med.
16:517–522. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Piotrowski WJ, Pietras T, Kurmanowska Z,
et al: Effect of paraquat intoxication and ambroxol treatment on
hydrogen peroxide production and lipid peroxidation in selected
organs of rat. J Appl Toxicol. 16:501–507. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stockley RA, Shaw J and Burnett D: Effect
of ambroxol of neutrophil chemotaxis in vitro. Agents Actions.
24:292–296. 1988. View Article : Google Scholar : PubMed/NCBI
|
